Found: 12
Select item for more details and to access through your institution.
Nicotine induces cell proliferation by β-arrestin--mediated activation of Src and Rb--Raf-1 pathways.
- Published in:
- Journal of Clinical Investigation, 2006, v. 116, n. 8, p. 2208, doi. 10.1172/JCI28164
- By:
- Publication type:
- Article
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.
- Published in:
- Nature Medicine, 2015, v. 21, n. 6, p. 560, doi. 10.1038/nm.3854
- By:
- Publication type:
- Article
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
- Published in:
- Nature Medicine, 2013, v. 19, n. 11, p. 1469, doi. 10.1038/nm.3352
- By:
- Publication type:
- Article
Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors.
- Published in:
- Oncogene, 2005, v. 24, n. 13, p. 2204, doi. 10.1038/sj.onc.1208206
- By:
- Publication type:
- Article
An Assessment of the Penile Squamous Cell Carcinoma Surfaceome for Biomarker and Therapeutic Target Discovery.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3636, doi. 10.3390/cancers15143636
- By:
- Publication type:
- Article
Novel mutant-selective EGFR kinase inhibitors against EGFR T790M.
- Published in:
- Nature, 2009, v. 462, n. 7276, p. 1070, doi. 10.1038/nature08622
- By:
- Publication type:
- Article
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
- Published in:
- International Journal of Cancer, 2007, v. 120, n. 9, p. 1874, doi. 10.1002/ijc.22423
- By:
- Publication type:
- Article
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 99, p. 1, doi. 10.1126/scitranslmed.3002442
- By:
- Publication type:
- Article
Pharmacological targeting of the pseudokinase Her3.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 12, p. 1006, doi. 10.1038/nchembio.1658
- By:
- Publication type:
- Article
Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of EGFR-mutant lung cancer.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 609, p. 1, doi. 10.1126/scitranslmed.abb3738
- By:
- Publication type:
- Article
Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines.
- Published in:
- Molecular Oncology, 2015, v. 9, n. 1, p. 260, doi. 10.1016/j.molonc.2014.08.011
- By:
- Publication type:
- Article